Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J van Deventer

Showing results (11-20 of 317) with videos related to

Pageof 32
Sort By:
Progress in Clinical and Biological Research|January 1, 1991
Immunotherapy of gram-negative septicemiaS J van Deventer
The European Journal of Surgery = Acta Chirurgica|February 24, 1999
Cytokines and mucosal inflammatory response in Crohn's diseaseS J van Deventer
Alimentary Pharmacology & Therapeutics|December 22, 1999
Review article: targeting TNF alpha as a key cytokine in the inflammatory processes of Crohn's disease--the mechanisms of action of infliximabS J van Deventer
Clinical Nutrition (Edinburgh, Scotland)|July 18, 2006
Immunomodulation of Crohn's disease using TNF-alpha neutralizing monoclonal antibodiesS J Van Deventer
Nederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[Immunology in medical practice. IV. Inflammatory bowel diseases: pathogenic starting points for specific therapy]S J van Deventer
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|May 31, 2001
Thermostatic and dynamic performance of an ultrasonic density probeJ van Deventer, J Delsing
Nederlands Tijdschrift Voor Geneeskunde|May 18, 1991
[Monoclonal anti-endotoxin antibodies in the treatment of patients with sepsis due to Gram-negative bacteria]P Speelman, S J van Deventer
Pharmacy World & Science : PWS|April 1, 1997
Monoclonal antibody therapy of inflammatory bowel diseaseS J van Deventer, L Camoglio
Intensive Care Medicine|January 1, 1997
Is G-CSF safe and useful in the treatment of infectious diseases in the non-neutropenic host?D Pajkrt, S J van Deventer
Nederlands Tijdschrift Voor Geneeskunde|April 18, 2001
[Activated protein C, coagulation, inflammation, and treatment of severe sepsis]S J van Deventer, D Pajkrt
Pageof 32

Showing results (11-20 of 317) with videos related to

Sort By:
Pageof 32
Progress in Clinical and Biological Research|January 1, 1991
Immunotherapy of gram-negative septicemiaS J van Deventer
The European Journal of Surgery = Acta Chirurgica|February 24, 1999
Cytokines and mucosal inflammatory response in Crohn's diseaseS J van Deventer
Alimentary Pharmacology & Therapeutics|December 22, 1999
Review article: targeting TNF alpha as a key cytokine in the inflammatory processes of Crohn's disease--the mechanisms of action of infliximabS J van Deventer
Clinical Nutrition (Edinburgh, Scotland)|July 18, 2006
Immunomodulation of Crohn's disease using TNF-alpha neutralizing monoclonal antibodiesS J Van Deventer
Nederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[Immunology in medical practice. IV. Inflammatory bowel diseases: pathogenic starting points for specific therapy]S J van Deventer
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|May 31, 2001
Thermostatic and dynamic performance of an ultrasonic density probeJ van Deventer, J Delsing
Nederlands Tijdschrift Voor Geneeskunde|May 18, 1991
[Monoclonal anti-endotoxin antibodies in the treatment of patients with sepsis due to Gram-negative bacteria]P Speelman, S J van Deventer
Pharmacy World & Science : PWS|April 1, 1997
Monoclonal antibody therapy of inflammatory bowel diseaseS J van Deventer, L Camoglio
Intensive Care Medicine|January 1, 1997
Is G-CSF safe and useful in the treatment of infectious diseases in the non-neutropenic host?D Pajkrt, S J van Deventer
Nederlands Tijdschrift Voor Geneeskunde|April 18, 2001
[Activated protein C, coagulation, inflammation, and treatment of severe sepsis]S J van Deventer, D Pajkrt
Pageof 32